ARTICLE | Company News
Altor in-licensing Genentech antibodies
February 13, 2008 3:01 AM UTC
Genentech (NYSE:DNA) granted Altor (Miramar, Fla.) exclusive, worldwide rights to develop and commercialize two antibodies: ALT-836 (formerly TNX-832), a chimeric antibody against tissue factor that i...